Postdoctoral position: human blood-brain barrier models to study B-cell pathobiology in multiple sclerosis (ETH Zurich and Novartis, Basel)
ETH Zurich, Bio Engineering Laboratory (Prof Andreas Hierlemann), Department of Biosystems Science and Engineering, Basel, with Novartis Biomedical Research
Who can apply: A background in immunology, neuroimmunology, neuroscience, bioengineering, biotechnology or a related discipline; experience with advanced in vitro models, blood-brain barrier biology, complex cell culture, neuroinflammation or immune cell biology is highly desirable; fluent English. No nationality restriction is… What is funded: A full-time (100%) postdoctoral position in Basel, fully funded for 2.5 years with annual contract renewal. The advert prints no salary figure. Deadline: 15 December 2026.
Read the full call and apply on the official page: ETH Zurich, Bio Engineering Laboratory (Prof Andreas Hierlemann), Department of Biosystems Science and Engineering, Basel, with Novartis Biomedical Research, official page.
Who can apply
- A background in immunology, neuroimmunology, neuroscience, bioengineering, biotechnology or a related discipline; experience with advanced in vitro models, blood-brain barrier biology, complex cell culture, neuroinflammation or immune cell biology is highly desirable; fluent English. No nationality restriction is stated.
Stage dates
Apply only through the ETH online portal with a half-page motivation statement, complete academic transcripts, a CV and at least two reference letters or referee contacts. Start date flexible but before February 2027.15 December 2026
Dates come from the funder's page for this round. When a round closes, the next round's dates replace these once the funder publishes them.